EdgarLookup

Vaxart, Inc. — SC 13G/A Filings

67 SC 13G/A filings on record

This page lists all SC 13G/A filings submitted to the SEC by Vaxart, Inc. (VXRT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Vaxart, Inc. has filed 67 SC 13G/A documents with the SEC since 2010. To view all SEC filings by Vaxart, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-C 10-K 10-K/A 10-K405 10-Q 10-Q/A 11-K 144 15-15D 25-NSE 3 3/A 4 4/A 424B1 424B2 424B3 424B4 424B5 425 5 5/A 8-A12B 8-A12G 8-K 8-K/A ARS CORRESP CT ORDER DEF 14A DEFA14A DEFC14A DEFM14A DFAN14A EFFECT FWP NO ACT NT 10-K NT 10-Q POS AM PRE 14A PREC14A PREM14A PREN14A PRER14A PRRN14A PX14A6G REGDEX S-1 S-1/A S-3 S-3/A S-3ASR S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SC TO-I SC TO-I/A SCHEDULE 13G SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
SC 13G/A SCHEDULE 13G/A 0001104659-24-022213 Feb 13, 2024
SC 13G/A 0001306550-23-009500 Jul 7, 2023
SC 13G/A 0001306550-23-005972 Feb 1, 2023
SC 13G/A 0000093751-23-000002 Jan 10, 2023
SC 13G/A 0000093751-22-000478 Mar 10, 2022
SC 13G/A 0000093751-22-000232 Feb 11, 2022
SC 13G/A NONE 0001567619-20-002624 Feb 11, 2020
SC 13G/A SABBY 13G-A VXRT 1.07.20 0001535610-20-000020 Jan 8, 2020
SC 13G/A 0000919574-18-001191 Feb 13, 2018
SC 13G/A 0000919574-17-001487 Feb 13, 2017
SC 13G/A 0000919574-17-001453 Feb 13, 2017
SC 13G/A KRENSAVAGE ASSET MANAGEMENT BIOTA 13G/A 12.31.2015 0001609251-16-000008 Feb 17, 2016
SC 13G/A 0000919574-16-010186 Feb 12, 2016
SC 13G/A SC 13G/A 0001144204-16-080278 Feb 10, 2016
SC 13G/A 0000919574-15-001991 Feb 17, 2015
SC 13G/A SCHEDULE 13G/A 0001144204-15-007822 Feb 11, 2015
SC 13G/A AMENDMENT NO. 2 0001144204-14-004635 Jan 29, 2014
SC 13G/A AMEND ]STATEMENT OF ACQUISITION OF BENEFICIAL OWNERSHIP BY INDIVIDUALS 0001320850-13-000002 Dec 6, 2013
SC 13G/A AMENDMENT NO. 1 0001214659-13-006461 Nov 14, 2013
SC 13G/A AMENDMENT TO 13/G 0001320850-13-000001 Jul 26, 2013
SC 13G/A AMENDMENT TO SCHEDULE 13G 0001144204-13-008103 Feb 13, 2013
SC 13G/A 2012 13G 0001037389-13-000020 Feb 12, 2013
SC 13G/A 0000932471-13-003950 Feb 12, 2013
SC 13G/A 0001086364-12-002674 Jul 11, 2012
SC 13G/A SCHEDULE 13G/A FOR NABI BIOPHARMACEUTICALS 0000904454-12-000115 Feb 14, 2012
SC 13G/A 0001086364-12-001847 Feb 13, 2012
SC 13G/A 13G/A 0001037389-12-000035 Feb 13, 2012
SC 13G/A 0000932471-12-001811 Feb 8, 2012
SC 13G/A SC 13G/A 0000950123-11-075451 Aug 10, 2011
SC 13G/A SCHEDULA13G/A FOR NABI BIOPHARMACEUTICALS 0000904454-11-000039 Feb 14, 2011
SC 13G/A 13G AMENDMENT 0001037389-11-000062 Feb 11, 2011
SC 13G/A 0001086364-11-003402 Feb 7, 2011
SC 13G/A SC 13G/A 0001104659-10-035000 Jun 22, 2010
SC 13G/A 13G/A 0001037389-10-000236 Feb 12, 2010
SC 13G/A NABI BIOPHARMACEUTICALS 0000902664-08-001239 Feb 14, 2008
SC 13G/A SC 13G/A 0000017283-08-000265 Feb 13, 2008
SC 13G/A SC 13G/A 0001104659-07-010417 Feb 14, 2007
SC 13G/A SC 13G/A 0000017283-07-000623 Feb 12, 2007
SC 13G/A 0000769993-07-000453 Feb 9, 2007
SC 13G/A 0000919574-06-000901 Feb 14, 2006
SC 13G/A AMENDMENT 0001104659-06-008719 Feb 14, 2006
SC 13G/A EARNEST PARTNERS LLC / NABI BIOPHARMACEUTICALS 0000950144-05-012695 Dec 13, 2005
SC 13G/A EARNEST PARTNERS, LLC/NABI BIOPHARMACEUTICALS 0000950144-05-006387 Jun 10, 2005
SC 13G/A 0000919574-05-000368 Feb 8, 2005
SC 13G/A HAI_NABI7 0000937394-04-000092 May 10, 2004
SC 13G/A 0000919574-04-000418 Feb 12, 2004
SC 13G/A HAI_NABI6 0000937394-04-000024 Feb 12, 2004
SC 13G/A SCHEDULE 13G/A 0000898430-04-001189 Feb 6, 2004
SC 13G/A 0000919574-03-000317 Feb 13, 2003
SC 13G/A ANNUAL 13G FILING-NABI5 0000937394-03-000029 Feb 13, 2003